Replay available

ExpreS2ion Biotech Holding AB (publ) (EXPRS2) Q2 2026 Earnings Call

ExpreS2ion Biotech Holding AB (publ) (STO: EXPRS2) Q2 2026 earnings conference call, held 2026-08-20. Replay captured from the company's public earnings webcast.

Thu, August 20, 2026 at 4:00 AMendedReplay
ExpreS2ion Biotech Holding AB (publ) (EXPRS2) Q2 2026 Earnings Call

Hosted by

Featured presenters

Ben Fransen

CEO

Keith Alexander

CFO

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Expres2ion Biotech Holding Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.253 -- 00:00:04.618 Welcome to today's event where we have the pleasure to present Expression Biotech. 00:00:04.618 -- 00:00:08.522 To help us through today's presentation we are joined by CEO Ben Fransen and CFO Keith 00:00:08.522 -- 00:00:13.788 Alexander. The topic for today of course the Q2 results fresh from the press this morning 00:00:13.788 -- 00:00:19.175 but maybe also more the strong data which I That's how you have 00:00:19.175 -- 00:00:22.137 communicated during the course 00:00:22.137 -- 00:00:27.840 on your breast cancer candidate. So that will be the main topics for today's presentation. 00:00:27.840 -- 00:00:31.102 As always, there's a box down below where you can ask questions. 00:00:31.102 -- 00:00:36.105 Do feel free to do it during the presentation, but we will take the Q&A in the end. 00:00:36.105 -- 00:00:41.209 And for informal, we have a fixed deadline at 10.30, so we will 00:00:41.209 -- 00:00:43.858 try and catch all the questions. 00:00:43.858 -- 00:00:46.819 But if not, then of course they are free to send it to you. 00:00:46.819 -- 00:00:50.280 But that was all the messaging before that. 00:00:50.280 -- 00:00:53.721 So now I will hand the stage over to you, Ben. 00:00:53.721 -- 00:00:56.782 Thank you very much, Michael. And good morning, everybody. 00:00:56.782 -- 00:01:01.143 And welcome to Expressions Q2 2026 Results Webcast. 00:01:01.143 -- 00:01:06.604 I'm Ben Fransen, CEO, and I'm joined today by our CFO, Kate Kees and Alexander. 00:01:06.604 -- 00:01:09.685 I will begin with our operational. 00:01:10.230 -- 00:01:15.511 to focus on ES2B C001. This will then take us through the Q&A to refer 00:01:15.511 -- 00:01:20.032 to our financial results, from which we will open for questions. 00:01:20.032 -- 00:01:25.153 Our a...